- Patient Education
Patient Education: Daratumumab & Daratumumab and Hyaluronidase-fihj - Monoclonal Ab - Immunotherapy
Patient Education: Daratumumab & Daratumumab and Hyaluronidase-fihj
DARATUMUMAB (DARZALEX)
NIH National cancer institute - cancer.gov site info
This page contains brief information about daratumumab and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.
US Brand Name(s): Darzalex
FDA Approved: Yes
Learn more: https://www.cancer.gov/about-cancer/treatment/drugs/daratumumab
MedlinePlus Information
A lay language summary of important information about this drug that may include the following:
warnings about this drug,
what this drug is used for and how it is used,
what you should tell your doctor before using this drug,
what you should know about this drug before using it,
other drugs that may interact with this drug, and
possible side effects.
Learn more: https://medlineplus.gov/druginfo/meds/a616002.html
Information on Darzalex website
Preparing for Treatment | DARZALEX® (daratumumab)
https://www.darzalex.com/darzalex-treatment/preparing-for-treatment
DARATUMUMAB AND HYALURONIDASE-FIHJ (DARZALEX FASPRO)
NIH National cancer institute - cancer.gov site info
This page contains brief information and collection of links to more information about the use of this drug, research results, and ongoing clinical trials.
US Brand Name(s): Darzalex Faspro
FDA Approved: Yes
Learn more: https://www.cancer.gov/about-cancer/treatment/drugs/daratumumabandhyaluronidase-fihj
MedlinePlus Information
A lay language summary of important information about this drug that may include the following:
warnings about this drug,
what this drug is used for and how it is used,
what you should tell your doctor before using this drug,
what you should know about this drug before using it,
other drugs that may interact with this drug, and
possible side effects.
Learn more: https://medlineplus.gov/druginfo/meds/a620040.html
Information on Darzalex Faspro Site:
https://news.darzalex.com/faspro/#how-is-darzalex-faspro-given
INTERNATIONAL MYELOMA FOUNDATION:
Understanding DARZALEX and DARZALEX FASPRO
https://www.myeloma.org/resource-library/understanding-darzalexr-darzalex-fasprotm
IMF Understanding Series
https://www.myeloma.org/cancer-information-series
IMF Resource Library
https://www.myeloma.org/publications-videos
https://www.youtube.com/c/IMFMyeloma/videos
Current FDA-Approved Medications for Multiple Myeloma Treatment
https://www.myeloma.org/multiple-myeloma-drugs
HEALTH TREE UNIVERSITY MYELOMA:
All About Darzalex (daratumumab)
HealthTree University for Multiple Myeloma Lectures
https://healthtree.org/myeloma/university/courses
HealthTree University Myeloma Videos
https://www.youtube.com/c/HealthTreeUniversity/videos
MULTIPLE MYELOMA RESERACH FOUNDATION:
Standard Treatments - Darzalex/Darzalex Faspro
https://themmrf.org/multiple-myeloma/treatment-options/standard-treatments/
MMRF Education Programs
https://themmrf.org/resources/education-programs/
MMRF Videos
https://www.youtube.com/user/TheMMRF/videos
References DARZALEX & DARZALEX FASPRO:
FDA Label Prescribing Information (Revised 03/2022)
Prescribing Information | DARZALEX FASPRO
FDA Label Prescribing Information (Revised 01/2022)
Prescribing Information | DARZALEX
Drug Label Information at DAILYMED - NIH-National Library of Medicine
DailyMed - DARZALEX FASPRO (daratumumab and hyaluronidase-fihj- human recombinant injection
DailyMed - DARZALEX- daratumumab injection, solution, concentrate
Other Resources
Patient and caregiver resources
- Multiple Myeloma Patient Education & Information on ongoing Multiple Myeloma Clinical Trials -